Skip to main content

Advertisement

Log in

Letter to the editor: In response to “influence of clinical, societal, and treatment variables on racial difference in ER-/PR- breast cancer survival” by Roseland ME, Schwartz K, Ruterbusch JJ, Lamerato L, Krajenta R, Booza J, Simon MS

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

The Original Article was published on 25 May 2017

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hilliard CB (2016) High osteoporosis risk among East Africans linked to lactase persistence genotype. BoneKEy Rep. doi:10.1038/bonekey.2016.30

    PubMed  PubMed Central  Google Scholar 

  2. Fu S, Hirte H, Welch S et al (2017) First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors. Invest New Drugs 35:324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Jiang Y, Gou H, Zhu J, Tian S, Yu L (2016) Lidocaine inhibits the invasion and migration of TRPV6-expressing cancer cells by TRPV6 downregulation. Oncol Lett 12(2):1164–1170

    PubMed  PubMed Central  Google Scholar 

Download references

Funding

I, Constance Hilliard, certify that I have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials presented in this letter-to-the-editor.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Constance Hilliard.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hilliard, C. Letter to the editor: In response to “influence of clinical, societal, and treatment variables on racial difference in ER-/PR- breast cancer survival” by Roseland ME, Schwartz K, Ruterbusch JJ, Lamerato L, Krajenta R, Booza J, Simon MS. Breast Cancer Res Treat 166, 321–322 (2017). https://doi.org/10.1007/s10549-017-4360-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-017-4360-z

Navigation